Clinical trial
Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects
NCT00432510 · Shire, Industry · Completed
Key facts
| NCT number | NCT00432510 |
|---|---|
| Title | Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects |
| Official title | Protocol LEVP2006-5: Pharmacokinetics of C1INH-nf in Hereditary Angioedema Subjects |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hereditary Angioedema |
| Intervention type | Drug |
| Interventions | C1 esterase inhibitor [human] (C1INH-nf) |
| Enrollment | 27 |
| Start date | Oct 9, 2006 |
| Primary completion | Feb 28, 2007 |
| Completion | Feb 28, 2007 |
| First posted | Feb 8, 2007 |
| Last update posted | Jun 3, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: